Ni particles were deposited on a-C films at temperatures from 350 to 500 °C, and reactions with the support were recorded at 600 up to 720 °C.
Only slightly lower levels of support were recorded for subsidies for health care benefits (78.2%) and for college tuition assistance to middle-income families (75.3%).
The presence of invasive procedures/monitoring and organ support was recorded.
Patient variables including demographics, haematological diagnosis, reason for ICU admission, type of transplant, APACHE II, number of organ failures and type of organ support were recorded.
Oxygenation and cardiovascular status, including use of inotropic or vasopressor support, was recorded prior to, during, and for a 48-hour period following the procedure.
Respiratory support was recorded as the number of days of assisted ventilation and the number of days of supplemental oxygen therapy at an FiO2 value >0.21.
The total number of days in the neonatal ward and the level of care the infant received each day of hospitalization (i.e. nasal oxygen, bCPAP, or no respiratory support) was recorded in the clinical study.
Episodes of sepsis, presence of intraventricular hemorrhage (IVH), presence of a patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC, ≥ Bell's Stage II) [ 17], and number of days of ventilator support were recorded as well.
Age, gender, weight, and diagnoses were recorded on admission to the pediatric intensive care unit and pediatric risk of mortality (PRISM), pediatric index of mortality (PIM), and pediatric logistic organ dysfunction (PELOD) scores, lactic acid, and need for inotropic drug support were recorded at the beginning of the CRRT.
The parameters necessary for the diagnosis of SIRS and SIRS with hypoperfusion (SIRS with an increase of lactate or at least one organ dysfunction as a result of the trauma) and shock (SIRS associated with hypotension refractory to fluid therapy and need of vasopressor support) were recorded.
